Clinical trial
A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
NCT00578825 is registered in ClinicalTrials.gov with Hospital Authority, Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
- Lead sponsor
- Hospital Authority, Hong Kong
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 340 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.